Specimen Collection in Patients with Cystic Fibrosis
CF_Specimens
What is the goal of the study?
Cystic Fibrosis is a recessive genetic disorder affecting approximately 30,000 people in the United States. Characterized by chronic pulmonary infections and poor nutritional status, the average life expectancy is approximately 30 years of age. With the support of the CF Foundation, basic scientists are exploring the etiology and cellular mechanisms involved in CF. Since 1986, scientists at the University of Washington have conducted research with funding from the CF Research Development Program. In addition, clinical researchers are collaborating with commercial biotechnical firms to develop new therapeutic agents aimed at amelioration and possibly cure of the disease. The University of Washington CF Center is involved in the CF Therapeutics Development Network, a consortium of CF clinical research groups formed to expedite the conduct of Phase I and II trials.
Who can participate in the study?
Please contact the study team listed below to learn more.